[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100528001":3},{"organization":4,"outcomesModule":7,"designInfo":58,"detailedDescription":64,"studyPopulation":57,"armGroups":65,"interventions":79,"overallOfficials":57,"centralContacts":95,"locations":101,"responsibleParty":415,"collaborators":57,"id":417,"slug":57,"hasResults":418,"nctId":419,"briefTitle":420,"officialTitle":421,"acronym":57,"eligibilityCriteria":422,"healthyVolunteers":418,"sex":423,"minAge":424,"maxAge":57,"enrollmentInfo":425,"targetDuration":57,"studyType":428,"phases":429,"briefSummary":432,"conditions":433,"keywords":57,"overallStatus":104,"whyStopped":57,"lastUpdateSubmitDate":435,"lastUpdatePostDateStruct":436,"startDateStruct":439,"completionDateStruct":441,"leadSponsor":443,"locationsCount":444},{"fullName":5,"class":6},"Hinova Pharmaceuticals Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":27,"otherOutcomes":57},[9,13,17,19,21,23],{"measure":10,"description":11,"timeFrame":12},"Incidences of Protocol-defined DLT during the DLT assessment period , characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), timing, seriousness, and relationship to study drugorally administered HP518 (Part 1)","To evaluate the safety and tolerability and determine the MTD and the RP2D of orally administered HP518 (Part 1)","28 DAYS",{"measure":14,"description":15,"timeFrame":16},"Incidence of Treatment-Emergent Adverse Events characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), timing, seriousness","To evaluate the safety of orally administered HP518 (Part 1)","Through study completion, an average of 1 year",{"measure":18,"description":15,"timeFrame":16},"Incidence of laboratory abnormalities, characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), and timing",{"measure":20,"description":15,"timeFrame":16},"Incidence of vital signs abnormalities characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), and timing",{"measure":22,"description":15,"timeFrame":16},"Incidence of ECG (PR, QRS, QT, and QTcF intervals) abnormalities characterized by type, frequency, severity (as graded by NCI CTCAE version 5.0), and timing",{"measure":24,"description":25,"timeFrame":26},"PSA50 response rate","Proportion of patients showing a PSA decline by ≥50% between baseline and Week 12 of dosing with HP518.","12 weeks",[28,31,33,35,37,39,41,45,48,51,54],{"measure":29,"description":30,"timeFrame":26},"area under the concentration-time curve (AUC)","Assessment of pharmacokinetic parameters of HP518",{"measure":32,"description":30,"timeFrame":26},"Maximum concentration (Cmax)",{"measure":34,"description":30,"timeFrame":26},"Time to maximum concentration (Tmax)",{"measure":36,"description":30,"timeFrame":26},"Apparent terminal elimination half-life (T1\u002F2)",{"measure":38,"description":30,"timeFrame":26},"apparent volume of distribution during the terminal phase after extravascular administration (Vz\u002FF)",{"measure":40,"description":30,"timeFrame":26},"oral clearance (CL\u002FF)",{"measure":42,"description":43,"timeFrame":44},"According to PCWG3","evaluate PSA50 response rate: PSA decline by≥50% between baseline and 4 weeks\u002F8 weeks\u002F12 weeks( only Part 1) of dosing with HP518","8 weeks",{"measure":46,"description":47,"timeFrame":16},"According to PCWG3, evaluate time to PSA progression","PCWG3 definition: PSA increase \\>25% and \\>2 ng\u002FmL above nadir, confirmed by progression at 2 time points at least 3 weeks apart) nadir, confirmed by progression at 2 time points at least 3 weeks apart)",{"measure":49,"description":50,"timeFrame":16},"Time to radiographic progression by investigator PCWG3 definition","using the RECIST v1.1 and PCWG3 definition",{"measure":52,"description":53,"timeFrame":16},"Evaluate the modified best overall response mBOR by investigator","According to RECIST (version 1.1) and PCWG3",{"measure":55,"description":56,"timeFrame":16},"analyze the efficacy of patients with different AR phenotypes(Part 2)","According to genetic testing results",null,{"allocation":59,"interventionModel":60,"interventionModelDescription":57,"primaryPurpose":61,"observationalModel":57,"timePerspective":57,"maskingInfo":62},"NON_RANDOMIZED","SEQUENTIAL","TREATMENT",{"masking":63,"maskingDescription":57,"whoMasked":57},"NONE","This First in Human dose escalation and expansion study of HP518 in patients with progressive mCRPC after NHA and chemotherapy is being conducted not only to evaluate the safety and tolerability of orally administered HP518, but also to provide preliminary efficacy for the reference of future studies.",[66,72,75],{"label":67,"type":68,"description":69,"interventionNames":70},"Part 1 - Dose Escalation, 400mg\u002Fd (Cohort1)","EXPERIMENTAL","Oral tablet(s), once daily in 28-day cycles",[71],"Drug: HP518 - Dose Escalation",{"label":73,"type":68,"description":69,"interventionNames":74},"Part 1 - Dose Escalation 500mg\u002Fd (Cohort 2)",[71],{"label":76,"type":68,"description":69,"interventionNames":77},"Part 2 - Dose Expansion Oral tablet(s)",[78],"Drug: HP518 -Dose Expansion",[80,87,90],{"type":81,"name":82,"description":83,"armGroupLabels":84,"otherNames":85},"DRUG","HP518 - Dose Escalation","Part 1: Dose escalation Daily oral dosage with the prescribed dose level based on Cohort",[67],[86],"Part 1 - Dose Escalation",{"type":81,"name":82,"description":83,"armGroupLabels":88,"otherNames":89},[73],[86],{"type":81,"name":91,"description":92,"armGroupLabels":93,"otherNames":94},"HP518 -Dose Expansion","Part 2: Dose expansion Daily oral dosage with the highest dose with acceptable toxicity (RP2D) based on data from Part 1.",[76],[76],[96],{"name":97,"role":98,"phone":99,"phoneExt":57,"email":100},"Qianrong Xiang","CONTACT","+86 28 8505 8465","qrxiang@hinovapharma.com",[102,119,131,139,151,161,174,186,198,210,222,230,242,254,266,278,290,301,312,324,336,348,358,369,380,392,404],{"facility":103,"status":104,"city":105,"state":106,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":109,"geoPoint":114,"contacts":115},"The Second Hospital Of Anhui Medical University","RECRUITING","Hefei","Anhui","China","CN",{"type":110,"coordinates":111},"Point",[112,113],117.28083,31.86389,{"lat":113,"lon":112},[116],{"name":117,"role":118,"phone":57,"phoneExt":57,"email":57},"Dexin Yu","PRINCIPAL_INVESTIGATOR",{"facility":120,"status":104,"city":121,"state":122,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"Beijing Cancer Hospital","Beijing","Beijing Municipality",{"type":110,"coordinates":124},[125,126],116.39723,39.9075,{"lat":126,"lon":125},[129],{"name":130,"role":118,"phone":57,"phoneExt":57,"email":57},"Jun Guo",{"facility":132,"status":104,"city":121,"state":122,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":133,"geoPoint":135,"contacts":136},"Beijing Friendship Hospital, Capital Medical University",{"type":110,"coordinates":134},[125,126],{"lat":126,"lon":125},[137],{"name":138,"role":118,"phone":57,"phoneExt":57,"email":57},"Yinong Niu",{"facility":140,"status":104,"city":141,"state":142,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"Chongqing University Cancer Hospital","Chongqing","Chongqing Municipality",{"type":110,"coordinates":144},[145,146],106.55771,29.56026,{"lat":146,"lon":145},[149],{"name":150,"role":118,"phone":57,"phoneExt":57,"email":57},"Hong Luo",{"facility":152,"status":104,"city":141,"state":142,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":153,"geoPoint":155,"contacts":156},"The Second Affiliated Hospital Of Chongqing Medical University",{"type":110,"coordinates":154},[145,146],{"lat":146,"lon":145},[157,159],{"name":158,"role":118,"phone":57,"phoneExt":57,"email":57},"Xian Yu",{"name":160,"role":118,"phone":57,"phoneExt":57,"email":57},"Qing Jiang",{"facility":162,"status":163,"city":164,"state":165,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"The First Affiliated Hospital Of Xiamen Univeristy","NOT_YET_RECRUITING","Xiamen","Fujian",{"type":110,"coordinates":167},[168,169],118.08187,24.47979,{"lat":169,"lon":168},[172],{"name":173,"role":118,"phone":57,"phoneExt":57,"email":57},"Jinchun Xing",{"facility":175,"status":104,"city":176,"state":177,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"Lanzhou University Second Hospital","Lanzhou","Gansu",{"type":110,"coordinates":179},[180,181],103.83987,36.05701,{"lat":181,"lon":180},[184],{"name":185,"role":118,"phone":57,"phoneExt":57,"email":57},"Li Yang",{"facility":187,"status":104,"city":188,"state":189,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":190,"geoPoint":194,"contacts":195},"The Third Affiliated Hospital of Southern Medical University","Guangzhou","Guangdong",{"type":110,"coordinates":191},[192,193],113.25,23.11667,{"lat":193,"lon":192},[196],{"name":197,"role":118,"phone":57,"phoneExt":57,"email":57},"Cundong Liu",{"facility":199,"status":104,"city":200,"state":201,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":202,"geoPoint":206,"contacts":207},"The Affiliated Hospital Of Guizhou Medical University","Guiyang","Guizhou",{"type":110,"coordinates":203},[204,205],106.71667,26.58333,{"lat":205,"lon":204},[208],{"name":209,"role":118,"phone":57,"phoneExt":57,"email":57},"Qiang Wang",{"facility":211,"status":104,"city":212,"state":213,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":214,"geoPoint":218,"contacts":219},"Henan Cancer Hospital","Zhengzhou","Henan",{"type":110,"coordinates":215},[216,217],113.64861,34.75778,{"lat":217,"lon":216},[220],{"name":221,"role":118,"phone":57,"phoneExt":57,"email":57},"Tiejun Yang",{"facility":223,"status":104,"city":212,"state":213,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":224,"geoPoint":226,"contacts":227},"Zhengzhou Central Hospital",{"type":110,"coordinates":225},[216,217],{"lat":217,"lon":216},[228],{"name":229,"role":118,"phone":57,"phoneExt":57,"email":57},"Kai Zhang",{"facility":231,"status":104,"city":232,"state":233,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":234,"geoPoint":238,"contacts":239},"Tongji Hospital","Wuhan","Hubei",{"type":110,"coordinates":235},[236,237],114.26667,30.58333,{"lat":237,"lon":236},[240],{"name":241,"role":118,"phone":57,"phoneExt":57,"email":57},"Zhiquan Hu",{"facility":243,"status":104,"city":244,"state":245,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":246,"geoPoint":250,"contacts":251},"Hunan Cancer Hospital","Changsha","Hunan",{"type":110,"coordinates":247},[248,249],112.97087,28.19874,{"lat":249,"lon":248},[252],{"name":253,"role":118,"phone":57,"phoneExt":57,"email":57},"Shusuan Jiang",{"facility":255,"status":104,"city":256,"state":257,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":258,"geoPoint":262,"contacts":263},"The First Affiliated Hospital Of Nanchang University","Nanchang","Jiangxi",{"type":110,"coordinates":259},[260,261],115.85306,28.68396,{"lat":261,"lon":260},[264],{"name":265,"role":118,"phone":57,"phoneExt":57,"email":57},"Cheng Zhang",{"facility":267,"status":104,"city":268,"state":269,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":270,"geoPoint":274,"contacts":275},"Liaoning Cancer Hospital & Institute","Shenyang","Liaoning",{"type":110,"coordinates":271},[272,273],123.43278,41.79222,{"lat":273,"lon":272},[276],{"name":277,"role":118,"phone":57,"phoneExt":57,"email":57},"Yu Zeng",{"facility":279,"status":104,"city":280,"state":281,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":282,"geoPoint":286,"contacts":287},"Shandong Provincial Hospital","Jinan","Shandong",{"type":110,"coordinates":283},[284,285],116.99722,36.66833,{"lat":285,"lon":284},[288],{"name":289,"role":118,"phone":57,"phoneExt":57,"email":57},"Hao Ning",{"facility":291,"status":104,"city":292,"state":281,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":293,"geoPoint":297,"contacts":298},"The Affiliated Hospital Of Qingdao University","Qingdao",{"type":110,"coordinates":294},[295,296],120.38042,36.06488,{"lat":296,"lon":295},[299],{"name":300,"role":118,"phone":57,"phoneExt":57,"email":57},"Haitao Niu",{"facility":302,"status":104,"city":303,"state":281,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":304,"geoPoint":308,"contacts":309},"Yantai Yuhuangding Hospital","Yantai",{"type":110,"coordinates":305},[306,307],121.44081,37.47649,{"lat":307,"lon":306},[310],{"name":311,"role":118,"phone":57,"phoneExt":57,"email":57},"Jitao Wu",{"facility":313,"status":104,"city":314,"state":315,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":316,"geoPoint":320,"contacts":321},"Shanghai Tenth People's Hospital","Shanghai","Shanghai Municipality",{"type":110,"coordinates":317},[318,319],121.45806,31.22222,{"lat":319,"lon":318},[322],{"name":323,"role":118,"phone":57,"phoneExt":57,"email":57},"Xudong Yao",{"facility":325,"status":104,"city":326,"state":327,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":328,"geoPoint":332,"contacts":333},"The First Affiliated Hospital Of Xi'An Jiaotong Univeristy","Xi’an","Shanxi",{"type":110,"coordinates":329},[330,331],113.52486,35.99785,{"lat":331,"lon":330},[334],{"name":335,"role":118,"phone":57,"phoneExt":57,"email":57},"Lei Li",{"facility":337,"status":104,"city":338,"state":339,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":340,"geoPoint":344,"contacts":345},"Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital","Chengdu","Sichuan",{"type":110,"coordinates":341},[342,343],104.06667,30.66667,{"lat":343,"lon":342},[346],{"name":347,"role":118,"phone":57,"phoneExt":57,"email":57},"Jing Liu",{"facility":349,"status":104,"city":338,"state":339,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":350,"geoPoint":352,"contacts":353},"West China Hospital Of Sichuan University",{"type":110,"coordinates":351},[342,343],{"lat":343,"lon":342},[354,356],{"name":355,"role":118,"phone":57,"phoneExt":57,"email":57},"Qiang Dong",{"name":357,"role":118,"phone":57,"phoneExt":57,"email":57},"Ping Feng",{"facility":359,"status":104,"city":360,"state":339,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":361,"geoPoint":365,"contacts":366},"The Affiliated Hospital Of Southwest Medical University","Luzhou",{"type":110,"coordinates":362},[363,364],105.42575,28.8903,{"lat":364,"lon":363},[367],{"name":368,"role":118,"phone":57,"phoneExt":57,"email":57},"Peng Qing",{"facility":370,"status":104,"city":371,"state":339,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":372,"geoPoint":376,"contacts":377},"Mianyang Central Hospital","Mianyang",{"type":110,"coordinates":373},[374,375],104.68168,31.46784,{"lat":375,"lon":374},[378],{"name":379,"role":118,"phone":57,"phoneExt":57,"email":57},"Xiaobo Du",{"facility":381,"status":104,"city":382,"state":383,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":384,"geoPoint":388,"contacts":389},"The Second Affiliated Hospital Of Kunming Medical University","Kunming","Yunnan",{"type":110,"coordinates":385},[386,387],102.71833,25.03889,{"lat":387,"lon":386},[390],{"name":391,"role":118,"phone":57,"phoneExt":57,"email":57},"Changxing Ke",{"facility":393,"status":104,"city":394,"state":395,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":396,"geoPoint":400,"contacts":401},"The Affiliated Hospital Of School Of Medicine Of Ningbo University","Ningbo","Zhejiang",{"type":110,"coordinates":397},[398,399],121.54945,29.87819,{"lat":399,"lon":398},[402],{"name":403,"role":118,"phone":57,"phoneExt":57,"email":57},"Zejun Yan",{"facility":405,"status":104,"city":406,"state":395,"zip":57,"country":107,"countryCode":108,"cosmosGeoPoint":407,"geoPoint":411,"contacts":412},"The First Affiliated Hospital of Wenzhou Medical University","Wenzhou",{"type":110,"coordinates":408},[409,410],120.66682,27.99942,{"lat":410,"lon":409},[413],{"name":414,"role":118,"phone":57,"phoneExt":57,"email":57},"Wei Chen",{"type":416,"investigatorFullName":57,"investigatorTitle":57,"investigatorAffiliation":57,"oldNameTitle":57,"oldOrganization":57},"SPONSOR","100528001",false,"NCT06155084","A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients","A Phase I\u002FII Open-Label Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer in China","Inclusion Criteria:\n\n1. Male, age ≥18\n2. Patients with androgen receptor (AR) ligand binding domain (LBD) activation mutations (the dose expansion part of stage II)\n3. Has histologically confirmed adenocarcinoma of the prostate, but there are no known significant neuroendocrine differentiation or small cell characteristics.\n4. Has metastatic disease documented by 2 or more bone lesions by bone scan or soft tissue disease progression observed by CT\u002FMRI at the beginning of study.\n5. the progression of the disease after receiving at least one new endocrine therapy and progressing with at least first-line chemotherapy.\n6. Must have recovered from toxicities related to any prior treatments\n7. Ongoing ADT with LHRH agonist\u002Fantagonist therapy or history of bilateral orchiectomy.\n8. ECOG performance status score of 0 to 1.\n\nExclusion Criteria:\n\n1. Combination of research or commercially available drugs targeting AR\n2. Has had any other anticancer treatments, including immunotherapy, chemotherapy, or radiotherapy (eg, 177LuPSMA-617, radium 223, PARP inhibitor) within 4 weeks prior to the first dose of HP518.\n3. Has gastrointestinal disorder affecting absorption (e.g., gastrectomy).\n4. Has significant cardiovascular disease.","MALE","18 Years",{"count":426,"type":427},84,"ESTIMATED","INTERVENTIONAL",[430,431],"PHASE1","PHASE2","The overall objective of this Phase 1 study is to evaluate the safety, PK,and anti-tumor activity of daily oral dosing with HP518,selecting the RP2D of HP518 based on assessments of patients with progressive mCRPC in dose-escalation phase",[434],"Metastatic Castration-resistant Prostate Cancer","2025-12-16",{"date":437,"type":438},"2025-12-22","ACTUAL",{"date":440,"type":438},"2023-12-26",{"date":442,"type":427},"2026-09",{"name":5,"class":6},27]